Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women

被引:45
作者
Angeles Martinez-Garcia, M. [1 ,2 ,3 ,4 ]
Gambineri, Alessandra [5 ]
Alpanes, Macarena [1 ,2 ,3 ,4 ]
Sanchon, Raul [1 ,2 ,3 ]
Pasquali, Renato [5 ]
Escobar-Morreale, Hector F. [1 ,2 ,3 ,4 ]
机构
[1] Hosp Univ Ramon y Cajal, Diab Obes & Human Reprod Res Grp, E-28034 Madrid, Spain
[2] Univ Alcala, E-28034 Madrid, Spain
[3] Inst Ramon y Cajal Invest Sanitaria IRYCIS, E-28034 Madrid, Spain
[4] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain
[5] Univ Alma Mater Studiorum, Policlin S Orsola Malpighi, Dept Clin Med, Div Endocrinol, I-40138 Bologna, Italy
关键词
molecular genetics; replication; confirmation; variants; single-nucleotide polymorphism; ANDROGEN EXCESS; ADRENAL-HYPERPLASIA; PREVALENCE; RISK; CRITERIA;
D O I
10.1093/humrep/des335
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Is there an association between polycystic ovary syndrome (PCOS) and the sex hormone-binding globulin (SHBG) rs1799941, rs6257, rs6259 and rs727428 variants in a large series of Mediterranean women? The rs727428 and rs6259 variants are associated with PCOS in Mediterranean women. The level of SHBG, the primary plasma transport protein for sex steroids, which regulates the bioavailability of these hormones to target tissues, is reduced in patients with PCOS. Single-nucleotide polymorphisms in the SHBG gene influence circulating SHBG levels in American patients with PCOS and may predict the development of type 2 diabetes. This was a genetic casecontrol association study including 1004 premenopausal Mediterranean women. In an Academic setting, we genotyped a clinical cohort consisting of 281 patients with PCOS and 142 women without any evidence of androgen excess, and a population-based cohort comprised of 581 unselected female blood donors from Spain and Italy. The latter included 31 patients with PCOS and 550 controls, of whom 298 had no evidence of any androgen excess disorder and were considered hyper-normal controls. Mutant alleles of the rs727428 variant were more frequent in patients with PCOS compared with controls and with hyper-normal controls. This association was independent of obesity. Carrying mutant alleles of rs727428 was found to be associated with a 1.29 odds ratio (OR) for PCOS, whereas carrying mutant alleles of rs6259 associated with a 0.68 OR for PCOS. The rs1799941 and rs6257 variants were not associated with PCOS. None of the SHBG variants influenced serum SHBG concentrations. The associations found here were relatively weak and, arising from a casecontrol study, do not necessarily indicate a causative role of the SHBG variants in the development of PCOS. Also, we studied different patients and controls from different sources, making some of the interpretations difficult. Finally, the rs1799941 variant was not in HardyWeinberg equilibrium in the small group of patients with PCOS recruited from the general population, yet this variant was not associated with PCOS. SHBG variants that influenced circulating SHBG levels in American patients with PCOS are also associated with this syndrome in Mediterranean women, pointing to SHBG as a candidate gene for PCOS. This study was supported by grants PI080944 and PI110357 from Instituto de Investigacin Carlos III, Spanish Ministry of Economy and Competitiveness. CIBERDEM is also an initiative of Instituto de Investigacin Carlos III. The Authors have no competing interests to declare.
引用
收藏
页码:3569 / 3576
页数:8
相关论文
共 26 条
[1]
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[2]
Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study [J].
Azziz, R ;
Hincapie, LA ;
Knochenhauer, ES ;
Dewailly, D ;
Fox, L ;
Boots, LR .
FERTILITY AND STERILITY, 1999, 72 (05) :915-925
[3]
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[4]
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[5]
Variant in sex hormone-binding globulin gene and the risk of prostate cancer [J].
Berndt, Sonja I. ;
Chatterjee, Nilanjan ;
Huang, Wen-Yi ;
Chanock, Stephen J. ;
Welch, Robert ;
Crawford, E. David ;
Hayes, Richard B. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (01) :165-168
[6]
SEX HORMONE-BINDING GLOBULIN AND FEMALE REPRODUCTIVE FUNCTION [J].
BOTWOOD, N ;
HAMILTONFAIRLEY, D ;
KIDDY, D ;
ROBINSON, S ;
FRANKS, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 53 (1-6) :529-531
[7]
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[8]
Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men. [J].
Ding, Eric L. ;
Song, Yiqing ;
Manson, JoAnn E. ;
Hunter, David J. ;
Lee, Cathy C. ;
Rifai, Nader ;
Buring, Julie E. ;
Gaziano, J. Michael ;
Liu, Simin .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1152-1163
[9]
Polymorphisms associated with circulating sex hormone levels in postmenopausal women [J].
Dunning, AM ;
Dowsett, M ;
Healey, CS ;
Tee, L ;
Luben, RN ;
Folkerd, E ;
Novik, KL ;
Kelemen, L ;
Ogata, S ;
Pharoah, PDP ;
Easton, DF ;
Day, NE ;
Ponder, BAJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (12) :936-945
[10]
A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs [J].
Escobar-Morreale, Hector F. ;
Sanchon, Raul ;
Millan, Jose L. San .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (02) :527-533